Dyovilda 50 Tablet

Dyovilda 50 Tablet Specification

Pacakaging (Quantity Per Box)
10 x 10 Tablets

Dosage Form
Oral Solid

Salt Composition
Vildagliptin

Packaging Type
Blister Pack

Origin of Medicine
India

Life Span
24 months from manufacturing date

Indication
For the management of blood glucose in Type 2 Diabetes

Brand Name
Dyovilda 50

Drug Type
Allopathic

Ingredients
Vildagliptin 50mg

Physical Form
Tablet

Function
Oral anti-diabetic medication

Recommended For
Type 2 Diabetes Mellitus Patients

Dosage
As directed by the physician

Dosage Guidelines
Take orally with or without food

Suitable For
Adults

Quantity
10 Tablets per Strip

Storage Instructions
Store in a cool, dry place away from direct sunlight

Formulation Strength
50 mg

Use With Caution
In patients with renal or hepatic impairment, or those with a history of pancreatitis

Minimum Order Quantity
1 box

Therapeutic Class
Dipeptidyl Peptidase-4 (DPP-4) Inhibitor

Route of Administration
Oral

Prescription Required
Yes

Side Effects
May include headache, dizziness, nasopharyngitis, and mild gastrointestinal disturbances

Marketed By
Dyotis Pharmaceutics Pvt. Ltd.

Dyovilda 50 Tablet Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

About Dyovilda 50 Tablet

Take advantage of the top-rated Dyovilda 50 Tablet-an eminent solution in diabetes management for adults. Harness the paragon of oral anti-diabetic medication, formulated with Vildagliptin 50 mg, ensuring enviable performance for Type 2 Diabetes Mellitus patients. This hot deal comes in a robust blister pack (10x10 tablets per box), maintaining efficacy and purity for 24 months. Manufactured by Dyotis Pharmaceutics Pvt. Ltd., Dyovilda 50 is recommended for those seeking a reliable DPP-4 inhibitor, distributed and exported with strict quality controls from India. Prescription required. Caution: Use in renal/hepatic impairment or pancreatitis history. Side effects may include mild headache or gastrointestinal disturbances. Store in a cool, dry environment.

Precision Application and Specific Usage of Dyovilda 50 Tablet

Dyovilda 50 Tablet is designed for oral administration, making it a convenient treatment option for adults with Type 2 Diabetes Mellitus. As a site-specific medication, it works internally to regulate blood glucose levels. The tablet should be used strictly under medical supervision, following your physician's dosage advice. Ideal for daily use, Dyovilda 50 aids in achieving stable glycemic control, whether administered with or without food, supporting an effective diabetes management regime.

Sample Policy and Payment Terms for Dyovilda 50 Tablet Orders

At Dyotis Pharmaceutics Pvt. Ltd., we ensure samples of Dyovilda 50 Tablet are shipped promptly, giving you the advantage of evaluating our product before large-scale expenditure. Our stock is ready to meet immediate demands, providing flexibility for distributors and traders. Payment terms are customer-friendly and samples are available upon request, supporting hassle-free transactions. Reach out for further details about our supply capabilities and to secure Dyovilda 50 Tablets for your business or clinic.

FAQ's of Dyovilda 50 Tablet:

Q: How should Dyovilda 50 Tablet be taken for effective results?

A: Dyovilda 50 Tablet should be taken orally as directed by your physician. It can be administered with or without food for adults diagnosed with Type 2 Diabetes Mellitus.

Q: What is the primary benefit of using Dyovilda 50 Tablet?

A: The key benefit of Dyovilda 50 Tablet is its influence on blood glucose levels, acting as a DPP-4 inhibitor to help adults with Type 2 Diabetes achieve improved glycemic control.

Q: When is caution advised in the usage of Dyovilda 50 Tablet?

A: Use with caution if you have renal or hepatic impairment, or a history of pancreatitis. Consult your healthcare provider before initiating treatment.

Q: What side effects may occur while using Dyovilda 50 Tablet?

A: Possible side effects include headache, dizziness, nasopharyngitis, and mild gastrointestinal disturbances. Report any persistent symptoms to your physician promptly.